questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Interleukines
Interleukine-9
Interleukine-9 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tests de laboratoire
Interleukine-9
Interleukine-9
Inflammation
Symptômes
5
Asthme
Réactions allergiques
Interleukine-9
Hyperréactivité bronchique
Troubles gastro-intestinaux
Interleukine-9
Démangeaisons
Difficultés respiratoires
Prévention
5
Prévention des maladies
Allergènes
Éducation des patients
Allergies
Alimentation
Inflammation
Contrôle environnemental
Allergènes
Traitements
5
Antihistaminiques
Interleukine-9
Anticorps monoclonaux
Asthme
Corticostéroïdes
Interleukine-9
Bronchodilatateurs
Asthme
Immunothérapie
Interleukine-9
Complications
5
Exacerbations d'asthme
Réactions allergiques
Maladies auto-immunes
Interleukine-9
Surinfections
Interleukine-9
Complications pulmonaires
Fibrose
Troubles cardiovasculaires
Interleukine-9
Facteurs de risque
5
Antécédents familiaux
Asthme
Pollution de l'air
Interleukine-9
Infections respiratoires
Interleukine-9
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Interleukine-9 : Questions médicales les plus fréquentes",
"headline": "Interleukine-9 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Interleukine-9 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Interleukine-9"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Interleukines",
"url": "https://questionsmedicales.fr/mesh/D007378",
"about": {
"@type": "MedicalCondition",
"name": "Interleukines",
"code": {
"@type": "MedicalCode",
"code": "D007378",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.465"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Interleukine-9",
"alternateName": "Interleukin-9",
"code": {
"@type": "MedicalCode",
"code": "D016906",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sushmita Chakraborty",
"url": "https://questionsmedicales.fr/author/Sushmita%20Chakraborty",
"affiliation": {
"@type": "Organization",
"name": "Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India."
}
},
{
"@type": "Person",
"name": "Dipendra Kumar Mitra",
"url": "https://questionsmedicales.fr/author/Dipendra%20Kumar%20Mitra",
"affiliation": {
"@type": "Organization",
"name": "Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India."
}
},
{
"@type": "Person",
"name": "Mattia Matasci",
"url": "https://questionsmedicales.fr/author/Mattia%20Matasci",
"affiliation": {
"@type": "Organization",
"name": "Philochem AG, CH-8112 Otelfingen, Switzerland."
}
},
{
"@type": "Person",
"name": "Dario Neri",
"url": "https://questionsmedicales.fr/author/Dario%20Neri",
"affiliation": {
"@type": "Organization",
"name": "Philochem AG, CH-8112 Otelfingen, Switzerland."
}
},
{
"@type": "Person",
"name": "Katharina F Kubatzky",
"url": "https://questionsmedicales.fr/author/Katharina%20F%20Kubatzky",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Personalized oncology, ethics and adherence to NCCN guidelines.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39400758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12032-024-02500-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Guideline adherence in ovarian cancer for surgical staging in the Netherlands.",
"datePublished": "2022-12-05",
"url": "https://questionsmedicales.fr/article/36270772",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ijgc-2022-003666"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Dutch guideline to prevent perioperative pulmonal complications: how is the adherence?]",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36300494",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Guideline Adherence and Practice Patterns in the Management of Medullary Thyroid Cancer.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36191377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2022.08.039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in Japanese workplaces: a survey-based classification of enterprises' practices into \"overscreening,\" \"underscreening,\" and \"guideline-adherence screening\".",
"datePublished": "2024-08-15",
"url": "https://questionsmedicales.fr/article/39148101",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-19775-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Interleukines",
"item": "https://questionsmedicales.fr/mesh/D007378"
},
{
"@type": "ListItem",
"position": 6,
"name": "Interleukine-9",
"item": "https://questionsmedicales.fr/mesh/D016906"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Interleukine-9 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Interleukine-9",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Interleukine-9",
"description": "Comment mesurer l'interleukine-9 ?\nQuels tests sont utilisés pour le diagnostic ?\nL'IL-9 est-elle liée à des maladies spécifiques ?\nQuels biomarqueurs sont associés à l'IL-9 ?\nL'IL-9 peut-elle être un indicateur de gravité ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Guideline+Adherence#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Interleukine-9",
"description": "Quels symptômes sont liés à l'IL-9 ?\nL'IL-9 provoque-t-elle des symptômes respiratoires ?\nY a-t-il des symptômes cutanés associés ?\nL'IL-9 est-elle liée à des symptômes gastro-intestinaux ?\nQuels signes cliniques sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Guideline+Adherence#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Interleukine-9",
"description": "Comment prévenir les maladies liées à l'IL-9 ?\nY a-t-il des vaccins pour l'IL-9 ?\nL'éducation des patients est-elle importante ?\nLes changements alimentaires peuvent-ils aider ?\nLe contrôle de l'environnement est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Guideline+Adherence#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Interleukine-9",
"description": "Comment traiter les niveaux élevés d'IL-9 ?\nY a-t-il des thérapies ciblées pour l'IL-9 ?\nLes corticostéroïdes affectent-ils l'IL-9 ?\nQuels médicaments sont utilisés pour l'asthme lié à l'IL-9 ?\nL'immunothérapie aide-t-elle avec l'IL-9 ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Guideline+Adherence#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Interleukine-9",
"description": "Quelles complications peuvent survenir avec l'IL-9 ?\nL'IL-9 peut-elle aggraver d'autres maladies ?\nY a-t-il des risques de surinfection ?\nDes complications pulmonaires sont-elles possibles ?\nL'IL-9 est-elle liée à des troubles cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Guideline+Adherence#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Interleukine-9",
"description": "Quels sont les facteurs de risque pour l'IL-9 ?\nL'exposition à la pollution augmente-t-elle le risque ?\nLe tabagisme influence-t-il l'IL-9 ?\nLes infections respiratoires sont-elles un facteur ?\nLe stress a-t-il un impact sur l'IL-9 ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Guideline+Adherence#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer l'interleukine-9 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-9 peut être mesurée par des tests ELISA dans le sérum ou les fluides biologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de cytokines sont utilisés pour évaluer l'IL-9."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 est associée à des maladies comme l'asthme et certaines allergies."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés à l'IL-9 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-9 est souvent mesurée avec d'autres cytokines comme l'IL-4 et l'IL-5."
}
},
{
"@type": "Question",
"name": "L'IL-9 peut-elle être un indicateur de gravité ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés d'IL-9 peuvent indiquer une inflammation sévère."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'IL-9 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des réactions allergiques, de l'asthme et des inflammations."
}
},
{
"@type": "Question",
"name": "L'IL-9 provoque-t-elle des symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 est impliquée dans l'hyperréactivité bronchique et l'asthme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent survenir dans des conditions allergiques liées à l'IL-9."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des symptômes gastro-intestinaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut être impliquée dans des troubles gastro-intestinaux allergiques."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des difficultés respiratoires, des éruptions cutanées et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées à l'IL-9 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les allergènes et adopter un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour l'IL-9 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour cibler l'IL-9."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les déclencheurs allergiques est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires peuvent-ils aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut aider à réduire l'inflammation et les symptômes."
}
},
{
"@type": "Question",
"name": "Le contrôle de l'environnement est-il crucial ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, réduire l'exposition aux allergènes environnementaux est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Comment traiter les niveaux élevés d'IL-9 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements anti-inflammatoires et des antihistaminiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies ciblées pour l'IL-9 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticorps monoclonaux ciblant l'IL-9 sont en développement pour traiter l'asthme."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils l'IL-9 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire les niveaux d'IL-9 et l'inflammation associée."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour l'asthme lié à l'IL-9 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les bronchodilatateurs et les corticostéroïdes sont couramment prescrits."
}
},
{
"@type": "Question",
"name": "L'immunothérapie aide-t-elle avec l'IL-9 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'immunothérapie peut aider à moduler la réponse immunitaire liée à l'IL-9."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'IL-9 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des exacerbations d'asthme et des réactions allergiques sévères."
}
},
{
"@type": "Question",
"name": "L'IL-9 peut-elle aggraver d'autres maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut exacerber des maladies auto-immunes et inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de surinfection ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients avec des niveaux élevés d'IL-9 peuvent être à risque de surinfections."
}
},
{
"@type": "Question",
"name": "Des complications pulmonaires sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut contribuer à des complications pulmonaires comme la fibrose."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des troubles cardiovasculaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre l'IL-9 et des troubles cardiovasculaires, mais c'est encore à étudier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'IL-9 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux d'allergies et d'asthme augmentent le risque d'IL-9 élevée."
}
},
{
"@type": "Question",
"name": "L'exposition à la pollution augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pollution de l'air est un facteur de risque connu pour les maladies liées à l'IL-9."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'IL-9 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter les niveaux d'IL-9 et aggraver les symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Les infections respiratoires sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections respiratoires peuvent déclencher une réponse immunitaire impliquant l'IL-9."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur l'IL-9 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et augmenter les niveaux d'IL-9."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
5 publications dans cette catégorie
Affiliations :
Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
4 publications dans cette catégorie
Affiliations :
Philochem AG, CH-8112 Otelfingen, Switzerland.
Publications dans "Interleukine-9" :
4 publications dans cette catégorie
Affiliations :
Philochem AG, CH-8112 Otelfingen, Switzerland.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Microbiology, Immunology and Parasitology Department, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.
International Corporation Laboratory of Agriculture and Agricultural Products Safety, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Brown Center for Immunotherapy, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
Successful personalized oncology today depends on clinicians taking advantage of the extensive, evidence-based information provided by the National Comprehensive Cancer Network (NCCN) Guidelines, whic...
Previous studies have shown low adherence to surgical staging guidelines in patients with clinical early-stage ovarian carcinoma. The aim of this study was to identify guideline adherence for surgical...
Patients with ovarian cancer and surgical staging registered in the Dutch Gynecological Oncology Audit between January 1, 2015 and December 31, 2019 in the Netherlands were included. Complete surgical...
604 patients underwent surgical staging, 365 (60%) underwent an incomplete staging procedure, 295 (81%) were registered with early-stage disease (International Federation of Gynecology and Obstetrics ...
Guideline adherence for staging was lower than expected and validation of data gave additional insights into the reasons that were contributing to incomplete surgical staging. Moreover, this analysis ...
Patients with a history of chronic obstructive pulmonary disease (COPD) or asthma undergoing surgery are at risk for developing postoperative pulmonary complications, associated with morbidity and mor...
Patients with a history of asthma and/or COPD who underwent non-thoracic surgery between January 2017 and July 2018 in our hospital, were included. Primary outcome was perioperative administration of ...
1,623 patients qualified for a preventative treatment. Overall, 653 patients (40%) received treatment according to protocol. The other 970 patients received no treatment (79%), another corticosteroid ...
The current guideline for prevention of postoperative pulmonary complications has not been implemented thoroughly at our hospital. The lack of adherence appears to be caused by lack in clarity in clin...
Little is known about nationwide practice patterns for the management medullary thyroid cancer (MTC) in relation to the 2015 American Thyroid Association guidelines and their impact on survival....
Using the Surveillance, Epidemiology, and End Results Program database (2000-2018), MTC treatment patterns were evaluated in terms of adherence to the 2015 American Thyroid Association guidelines acro...
A total of 3332 patients with MTC were identified. Of which, 53.8%, 33.2%, and 11.4% of patients had localized, regional, and distant disease, respectively. In patients with locoregional disease, the ...
The rate of guideline-concordant surgery for locoregional MTC increased after guideline publication in 2015, with an observed prolongment in OS and DSS. Chemotherapy use among patients with distant di...
Workplace cancer screening programs are determined as part of an employee's benefits package and health checkups are perceived positively. However, the current status of workplace cancer screening pro...
A cross-sectional study design was employed. Data were obtained from a survey conducted by the "Corporate Action to Promote Cancer Control" between November and December 2022 among registered partner ...
The guideline-adherence rates for colorectal, breast, and cervical cancer screenings in the workplace were 12.7%, 3.0%, and 8.8%, respectively. Enterprises had lower adherence to screening guidelines ...
Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in the workplace was suboptimal among Japanese enterprises. Therefore, appropriate cancer screening measures and...
Despite the availability of evidence-based inflammatory bowel disease (IBD) guidelines, suboptimal care persists. There is little published research assessing barriers to IBD guideline adherence....
To identify barriers to IBD guideline adherence including gastroenterologists' knowledge and attitudes towards guidelines....
An online cross-sectional survey of 824 Australian gastroenterologists was conducted from April to August 2018, with 198 (24%) responses. A novel survey was developed that was informed by the theoreti...
Confidence in guideline recommendations was high; however, referral to them was low. The European Crohn's and Colitis Organisation guidelines were referred to most commonly (43.6%). In multivariate an...
Although gastroenterologists have high confidence in guidelines, they use them infrequently, primarily due to specifics being difficult to remember and lack of time. Self-reported confidence in an are...
Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of...
To improve the management of cancer related pain, the National Comprehensive Cancer Network (NCCN) publishes the Adult Cancer Pain guideline on an annual basis. However, a large majority of oncology p...
The spleen is responsible for blood filtration and mounting an immune response against pathogens. In some people the spleen must be surgically removed because of traumatic events or oncological and he...
Traumatic brain injury (TBI) is a leading cause of death and morbidity worldwide. Evidence-based guidelines for managing severe TBI have been available for over 25 years. However, adherence to guideli...
A structured literature search was conducted using the MEDLINE...
Nine cohort studies were identified that fulfilled the inclusion criteria and answered the clinical question. A review of these papers was conducted....
Mortality after severe TBI improves with increasing adherence to evidence-based guidelines in both adults and children. The evidence also suggests that compliance with guideline recommendations result...